BioNeex

United States - Syracuse, New York

• 20/02/2024
• Seed
• $500,000

BioNeex is the first biopharma R&D business development platform, an AI-powered two-sided drug candidates marketplace. It connects biotech, biopharma companies, and venture capital firms to facilitate licensing, co-development partnership deals for preclinical and clinical-stage drug candidates, and investments.

On one side, the platform enables biotech and biopharma companies to list their drug candidates and directly contact hundreds of biopharma companies and venture capital firms actively seeking innovative development-stage assets (Preclinical to Phase III) for in-licensing, co-development partnership, and investment.

On the other side, the platform enables biopharma companies and venture capital firms to identify and access innovative development-stage assets (Preclinical to Phase III) posted directly by biotech and biopharma companies and directly contact them with one click.

In essence, BioNeex provides an AI-powered platform for biotech, biopharma companies, and venture capital firms, where they can meet and create R&D partnerships or investment deals.

BioNeex's vision is helping preclinical and clinical-stage biotech and biopharma companies gain for their medicines in development vital exposure to the right partners and investors at the right time, which will increase the likelihood of moving these innovative drug candidates into the next stage of development and, ultimately to the patients as novel medicines.

Related People

Dr. Smbat RafayelyanFounder

Germany - Berlin, Berlin

Entrepreneurship and Business Development with focus on the Biopharma industry.

LinkedIn https://www.linkedin.com/in/dr-smbat-rafayelyan/